The Eighth Circuit is currently reviewing Arkansas’s ban on pharmacy benefit managers (PBMs) owning pharmacies, marking a significant legal debate over competition in the pharmacy sector. Arkansas argues that this legislation, enacted as Act 624, is essential to protect patients from predatory practices by PBMs. They claim that the law promotes fair competition by preventing PBMs from integrating pharmacy ownership.
On the other hand, PBM representatives argue that the law is a form of illegal favoritism, constituting a breach of the Dormant Commerce Clause. They assert that the legislation unfairly targets out-of-state companies while exempting local chains like Walgreens and Kroger. Concerns were raised about the potential disruption to pharmacies and patients, with predictions that many pharmacies could close, leaving a significant number of Arkansans in need of new prescription options.
During the hearing, judges questioned the rationale behind the ban and whether it truly aimed for patient protection or if it served a protectionist agenda against larger out-of-state businesses. The decision from the Eighth Circuit is awaited and could have substantial implications for the pharmacy landscape in Arkansas and beyond.
